To determine physician characteristics associated with the use of bone densitometry (BD), we conducted a cross-sectionai survey of primary care practitioners in an urban community hospital. Participants were internists, geriatricians, and family practitioners. Seventy-two percent of the physicians never used BD. There was no association between physician or practice characteristics and BD use. Bone densitometry users were more likely than nonusers to treat their patients with osteoporosis or at risk of developing it. Self-reported barriers to use included cost, unfamiliarity with guidelines, uncertainty with clinical applicability, minimal impact on treatment decisions, and availability. In conclusion, although it has been shown that osteoporotic women who are aware of their BD results are more likely to accept treatment, further attention should be paid to primary care practitioners' attitudes, knowledge, and behavior regarding the use of BD in the management of osteoporosis. KEY WORDS; bone densitometry; osteoporosis; physician knowledge; attitudes; behaviors. ~'~steoporosis is believed to result in at least 1,3 million ~.Jfractures in the United States each year. These fractures result in significant morbidity and mortality in the fastest growing segment of our population, the elderly, Because of this, osteoporosis is a significant health con cern that may eventually cost the United States between $4 billion and $60 billion a year, ~,s Efforts aimed at maintaining bone mass are consid ered crucial in decreasing the risk of fractures, s r, Several studies have shown that for 1 SD decrement in bone mass, fracture risk increases as much as 50% to ]00%. 4
~'~steoporosis is believed to result in at least 1,3 million ~.Jfractures in the United States each year. These fractures result in significant morbidity and mortality in the fastest growing segment of our population, the elderly, Because of this, osteoporosis is a significant health con cern that may eventually cost the United States between $4 billion and $60 billion a year, ~,s Efforts aimed at maintaining bone mass are consid ered crucial in decreasing the risk of fractures, s r, Several studies have shown that for 1 SD decrement in bone mass, fracture risk increases as much as 50% to ]00%. 4 Recently, the efficacy of the bisphosphonate alendronate was demonstrated by documenting a 480/0 reduction in vertebral fracture rates in conjunction with a 9% increase in bone density. 7 The Postmenopausal Estrogen/Proges tin Interventions (PEPI} Trial also demonstrated as much as a 5% increase in bone mineral density with hormone replacement therapy. ~ Bone mass can now be measured in a safe, reliable and accurate manner using bone densi-tometry (BD). especially with the development of dualenergy x-ray absorptiometry (DEXA),"
Bone densitometry may have an expanded role in the management of patients with osteoporosis, especially given the multiple options for treatment, lr"l~ Because screening all perimenopausal women is costly, several experts have published selective screening practice guidelines for women at high risk of osteoporosis: women with estrogen deficiency considering replacement therapy, patients with radiographic abnormalities suggesting osteoporosis, patients on longterm glucocorticoid or anticonvulsant therapy, and patients with primary hyperparathyroidism. '-~.13-1~ However, there is no evidence linking BD use with reduced fracture incidence.
Rubin and Cummings reported that women's knowl edge of their BD results influenced their decision to accept therapy for osteoporosis, 1' It has not previously been reported whether the physician's knowledge of patients' BD results influences treatment recommendations.
Given the uncertain utility of BD in the clinical setting. we sought to characterize the use of BD by primary care practitioners (PCPs) affiliated with a community hospital,
METHODS
In January 1994. a questionnaire was mailed to all active attending physicians in internal medicine and fam ily medicine with admitting privileges at St. Mary's Hospi tal, a 250-bed urban community teaching hospital affiliated with the University of Rochester School of Medicine and Dentistry. These physicians provide care to a popula tion of patients with diverse socioeconomic backgrounds, and practice in private, hospital sponsored, and hospital based settings. The questionnaire addressed PCPs' prac tice characteristics, their knowledge and attitudes regarding the diagnosis and treatment of osteoporosis, and their use of BD.
All categorical variables were analyzed with the X ~ or Fisher's Exact Test where appropriate. The primary de pendent variable was BD use (ordered at least once a year) versus nonuse (never ordered). Ordering a BD at least once a year implied use of the test at least once within a year for any patient, not annual use for an indi vidual patient,
RESULTS

Demographics
The response rate was 75o/o (62/81), The PCPs were internists (47.5%), family practitioners (47.5%), or geria tricians (5%). The majority of physicians were male (62%), 781 JGIM older than 40 years (52.4%), in practice for less than 10 years (57.4%), and had a practice of more than 750 patients (63.2%), The majority of their patients were white (7(YYo of the physicians reported >50% of their patients were white) and female (72.2% of the physicians reported >50% of their patients were female), Twenty-two percent of the physicians identified more than half of their female patients as perimenopausal or postmenopausal. Only 10~ of the physicians perceived that the prevalence of osteoporosis was greater than 5(YYo in their practices: 60% of the physicians reported that less than half of their female patients were at risk of osteoporosis, Among their patients, physicians identified white postmenopausal women as the group at greatest risk of osteoporosis,
Knowledge and Treatment
Of the respondents. 68% and 71% felt conffortable with their knowledge regarding the diagnosis of os teoporosis and treatment of osteoporosis, respectively, However. few physicians (5,2%) reported treating all patients with osteoporosis or at risk of developing it. When these physicians do treat patients at risk. they use calcium (85,5%) or estrogen replacement therapy (90.9%) or both.
Bone Densitometry Use
Bone densitometry was never used by 72% of physicians, Only 5% of physicians used it more than 5 times per year. The physician identified barriers to ordering BD included potential cost to the patient (50%). unfamiliarity with BD guidelines (41%). uncertainty with the clinical applicability of results (52%), minimal impact on treat ment decisions (21%). availability of BD (21%), mid other factors (7%).
Univariate comparisons (Table 1) revealed no associa tion between BD use and physician characteristics or physician's conffort with the diagnosis and treatment of osteoporosis. There was no association between physi ciml-reported barriers to BD use mid reported BD use, When evaluating physicians' treatment practices, we found 70% of BD users versus 3(YYo of BD nonusers treat more than 50% of their patients with osteoporosis or at risk of developing it (p .005), Bone densitometry users' medical practices were not more likely to have increased numbers of female, perimenopausal or postmenopausal white women, or patients perceived to be at risk of osteoporosis.
DISCUSSION
Despite the evidence supporting a role for BD in pri mary care. we found the majority of the physicians simply did not use it, The physicians cited several practical reasons for not using BD. Fifty percent of them cited cost as a reason for not using the test. Although third-party payers are in the process of creating expanded criteria for payment, there is concern that patients may incur some (or all) of the cost until those criteria are implemented.
It is not surprising that 52% of these physicians do not order the test because they are uncertain of the utility of the information obtained. This may mean that physicimls need more evidence for the effectiveness, rather than efficacy, of BD. There is no direct evidence that BD use results in reduced fracture rates. However, indirect evidence suggests that outcomes are improved by treating patients with low bone density. 7`s In addition, 41% of these physicians do not use BD more often because they are not fmniliar with published guidelines, suggesting that physicians need more education regarding the use of Limitations of this study must be acknowledged. We did not inquire about the patients" comorbidities and their influence on the diagnosis and treatment of osteoporosis.
We relied entirely on physician selSreport (the physician's actual behavior could not be confirmed), which may reflect attitudes about practice rather than true practice. In addition, this study was performed at a single institution, 
